期刊文献+

一种新颖的阳离子非病毒基因载体Chitosan-g-PEI-g-PEG-OH的性能研究

Evaluation of the Properties of a Novel Cationic Non-viral Gene Carrier Chitosan-g-PEI-g-PEG-OH
下载PDF
导出
摘要 研究了新型阳离子聚合物Chitosan-g-PEI-g-PEG-OH的性能,重点考察其粒度,基因转染效率与细胞毒性,探讨了其作为基因载体的可能性.通过动态光散射仪(DSL)、透射电镜(TEM)观察了Chitosan-g-PEI-g-PEG-OH与DNA自组装形成的颗粒形态及粒径,Chitosan-g-PEI-g-PEG-OH可复合DNA形成粒径160~210 nm的纳米复合物,适合进入细胞.使用MTT比色法分析Chitosan-g-PEI-g-PEG-OH的毒性并与PEI,PEI-g-PEG-OH比较.选用增强型绿色荧光蛋白(EGFP)转染Hela细胞,应用流式细胞术检测转染效率.新型阳离子多聚物Chitosan-g-PEI-g-PEG-OH在提高基因转染效率的同时降低了其细胞毒性,有望成为基因转移的有效载体. Chitosan-g-PEI-g-PEG-OH is a new cationic copolymer.The influencing factors of Chitosan-g-PEI-g-PEG-OH gene delivery efficiency were studied,and these properties demonstrated that this copolymer could be used as the gene carrier.The surface topography and sizes of self-assembly complexes of the Chitosan-g-PEI-g-PEG-OH and DNA were observed through DSL and TEM,and the main size of the Chitosan-g-PEI-g-PEG-OH/DNA complex was approximately 160~210 nm spherical particles.The particles with the size were suitable for entry into cells.Cytotoxicity of Chitosan-g-PEI-g-PEG-OH was evaluated in MTT method and compared with Cytotoxicity of PEI and PEI-g-PEG-OH.Chitosan-g-PEI-g-PEG-OH/pEGFP complexes were transfected into Hela,and the effects of the transfection conditions were evaluated with FACS.Chitosan-g-PEI-g-PEG-OH copolymer presented a lower cytotoxicity and higher transfection efficiency than PEI.The results show that the copolymer is quite promising as an efficient carrier for gene delivery.
出处 《湖南大学学报(自然科学版)》 EI CAS CSCD 北大核心 2013年第12期74-79,共6页 Journal of Hunan University:Natural Sciences
基金 国家自然科学基金资助项目(2010SK2001)
关键词 阳离子聚合物 DNA 细胞毒性 基因载体 转染 cation polymer DNA cytotoxicity gene carrier transfection
  • 相关文献

参考文献26

  • 1HOWARTH J L, LEE Y B, UNEY J B. Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Is- sue: ETCS-UK 1 day meeting on genetic manipulation of cells) [J]. Cell Biology and Toxicology,2010, 26(1): 1-20.
  • 2LUFINO M M, EDSER P A, WADE-MARTINS R. Ad- vances in highapacity extrachromosomal recto rtechnology: episomal mainte-nance, vector delivery, and transgene expres- sion[J]. Molecular Therap, 2008,16 (9).. 1525-1538.
  • 3LEHRMAN S. Virus treatment questioned after gene therapy death[J].Nature, 1999, 401:517-518.
  • 4LIU Q, MURUVE D A. Molecular basis of theinflammatory response to adenovirus vectors [J].Gene Therapy, 2003, 10: 935-940.
  • 5SUN J Y, ANAND-JAWA V, CHATTERJEE S, et al. Im- mune responses to adeno-assoeiated virus and its recombinant vectors[J]. Gene Therapy, 2003, 10 : 964- 976.
  • 6GORE M E. Adverse effects of gene therapy: gene therapy can cause leukaemia: no shock, mild horror but a probe [J]. Gene Therapy, 2003, 10:4.
  • 7STEFAAN C, SMEDT D, DEMEESTER J, et al. Cationic polymer based gene delivery systems[J]. Pharmaceutical Re- search, 2000, 17(2) :113-126.
  • 8GOVENDER T, STOLNIK S, GARNETT M C, et al. PLGA nanoparticies prepared by nanoprecipitation: drug loading and release studies of a water soluble drug [J]. Journal of Con- trolled, 1999, 57(2): 171-185.
  • 9STUART C M, HUMPHERY H Y, DOBSON J. Magnetic nanoparticles for gene and drug delivery [J]. International Journal of Nanomedicine, 2008(3) : 169- 180.
  • 10MARKUS E, CORINNA P, CARSTEN R. Self-Assembly of ternary insulin-polyethylenimine(PEI)-DNA nanoparticles for enhanced gene delivery and expression in alveolar epithelial cells[J]. Biomacromolecules, 2009, 10(10): 2912-2920.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部